GSTM1 and hydrops fetalis: While reports of Hb Adana (α2 or α1) from other countries are limited, in our Clinic, the recent frequency of this mutation seems high (16%) in Indonesian α-thal patients with clinically manifested thalassemia intermedia and thalassemia major including hydrops fetalis cases (unpublished data).